FDA Inspection
Haupt Pharma Muenster GmbHHaupt Pharma Muenster GmbH – FDA Inspection, Jul 6, 2018
Record Details
This FDA Inspection record concerns Haupt Pharma Muenster GmbH, with an inspection on July 6, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 4cba233f-342f-4540-b7e3-f0dff689c21f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1059379
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Haupt Pharma Muenster GmbH
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 24, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 21, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 30, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Haupt Pharma Muenster GmbH
- FDA Inspection 1222114 - 2021-11-24
- FDA Inspection 875643 - 2014-03-21
- FDA Inspection 775211 - 2012-03-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.